Contract facts
NONENo full NAICS 325412 intel page yet. Browse NAICS intelligence
SANOFI TRAVEL VACCINES is a federal NONE award for Division 1200 held by Sanofi Pasteur Inc. Estimated value $200K ($140K obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: SWIFTWATER PA.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (133 days remaining). Agencies typically plan 12–18 months ahead — at 4.4 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordSanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 15F06726F0000243?
15F06726F0000243 (SANOFI TRAVEL vaccines) is a Division 1200 award with a potential value of $200K, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 15F06726F0000243?
Division 1200 awarded 15F06726F0000243 to Sanofi Pasteur Inc (potential $200K).
Who is the incumbent on 15F06726F0000243?
Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Sanofi Pasteur Inc’s 15F06726F0000243 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.